GPT and cancer: Both these conclusions need to be investigated with future works; however, the results presented here demonstrate the potential of the blood-based C-Circle assay as a clinical diagnostic for ALT+ cancer, which is required for the development of ALT-targeted therapies as well as for the diagnosis and monitoring of ALT+ cancer.